Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Bruno M. Roatt"'
Autor:
Danniele L. Vale, Camila S. Freitas, Vívian T. Martins, Gabriel J. L. Moreira, Amanda S. Machado, Fernanda F. Ramos, Isabela A. G. Pereira, Raquel S. Bandeira, Marcelo M. de Jesus, Grasiele S. V. Tavares, Fernanda Ludolf, Miguel A. Chávez-Fumagalli, Alexsandro S. Galdino, Ricardo T. Fujiwara, Lílian L. Bueno, Bruno M. Roatt, Myron Christodoulides, Eduardo A. F. Coelho, Daniela P. Lage
Publikováno v:
Biology, Vol 12, Iss 6, p 851 (2023)
Visceral leishmaniasis (VL) in the Americas is a chronic systemic disease caused by infection with Leishmania infantum parasites. The toxicity of antileishmanial drugs, long treatment course and limited efficacy are significant concerns that hamper a
Externí odkaz:
https://doaj.org/article/02ab76904ab1425b9580143214a0b6b9
Autor:
Hugo O. Valdivia, Bruno M. Roatt, Rodrigo de Paula Baptista, Jennifer Ottino, Anderson Coqueiro-dos-Santos, Mandy J. Sanders, Alexandre B. Reis, James A. Cotton, Daniella C. Bartholomeu
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 12 (2022)
Visceral leishmaniasis is an important global health problem with an estimated of 50,000 to 90,000 new cases per year. VL is the most serious form of leishmaniasis as it can be fatal in 95% of the cases if it remains untreated. VL is a particularly a
Externí odkaz:
https://doaj.org/article/0c34e21bff514f769362c18087968f16
Autor:
Tauane G. Soyer, Fernanda F. Ramos, Isabela A. G. Pereira, Daniela P. Lage, Raquel S. Bandeira, Marcelo M. de Jesus, Guilherme P. Costa, Amanda S. Machado, Camila S. Freitas, Danniele L. Vale, Vívian T. Martins, Alexsandro S. Galdino, Miguel A. Chávez-Fumagalli, Daniel Menezes-Souza, Mariana C. Duarte, Bruno M. Roatt, Eduardo A. F. Coelho, Grasiele S. V. Tavares
Publikováno v:
Pathogens, Vol 12, Iss 2, p 314 (2023)
Leishmania amazonensis can cause cutaneous and visceral clinical manifestations of leishmaniasis in infected hosts. Once the treatment against disease is toxic, presents high cost, and/or there is the emergence of parasite-resistant strains, alternat
Externí odkaz:
https://doaj.org/article/0e72ffa459d24221bdbdd07350467a1d
Autor:
Débora V.C. Mendonça, Grasiele S.V. Tavares, Daniela P. Lage, Tauane G. Soyer, Lívia M. Carvalho, Daniel S. Dias, Patrícia A.F. Ribeiro, Flaviano M. Ottoni, Luciana M.R. Antinarelli, Danniele L. Vale, Fernanda Ludolf, Mariana C. Duarte, Elaine S. Coimbra, Miguel A. Chávez-Fumagalli, Bruno M. Roatt, Daniel Menezes-Souza, José Mário Barichello, Ricardo J. Alves, Eduardo A.F. Coelho
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 109, Iss , Pp 779-787 (2019)
New therapeutic strategies against leishmaniasis are desirable, since the treatment against disease presents problems, such as the toxicity, high cost and/or parasite resistance. As consequence, new antileishmanial compounds are necessary to be ident
Externí odkaz:
https://doaj.org/article/e7491b6934e34937acd1c17a6771ef90
Autor:
Daniela P. Lage, Danniele L. Vale, Flávia P. Linhares, Camila S. Freitas, Amanda S. Machado, Jamille M. O. Cardoso, Daysiane de Oliveira, Nathália C. Galvani, Marcelo P. de Oliveira, João A. Oliveira-da-Silva, Fernanda F. Ramos, Grasiele S. V. Tavares, Fernanda Ludolf, Raquel S. Bandeira, Isabela A. G. Pereira, Miguel A. Chávez-Fumagalli, Bruno M. Roatt, Ricardo A. Machado-de-Ávila, Myron Christodoulides, Eduardo A. F. Coelho, Vívian T. Martins
Publikováno v:
Vaccines, Vol 10, Iss 7, p 1146 (2022)
Currently, there is no licensed vaccine to protect against human visceral leishmaniasis (VL), a potentially fatal disease caused by infection with Leishmania parasites. In the current study, a recombinant chimeric protein ChimT was developed based on
Externí odkaz:
https://doaj.org/article/73eb6f48a1ba4ae29ec937b48a427241
Autor:
Daniela P. Lage, Patrícia A.F. Ribeiro, Daniel S. Dias, Débora V.C. Mendonça, Fernanda F. Ramos, Lívia M. Carvalho, Bethina T. Steiner, Grasiele S.V. Tavares, Vívian T. Martins, Amanda S. Machado, João A. Oliveira-da-Silva, Thaís T.O. Santos, Camila S. Freitas, Jamil S. Oliveira, Bruno M. Roatt, Ricardo A. Machado-de-Ávila, Maria V. Humbert, Myron Christodoulides, Eduardo A.F. Coelho
Publikováno v:
Vaccines, Vol 8, Iss 2, p 289 (2020)
Background: Leishmaniases are neglected diseases caused by infection with Leishmania parasites and there are no human vaccines in use routinely. The purpose of this study was to examine the immunogenicity of ChimeraT, a novel synthetic recombinant va
Externí odkaz:
https://doaj.org/article/0d348c69932349ab9c3924f3d9114030
Autor:
Rory C. F. De Brito, Jamille M. De O. Cardoso, Levi E. S. Reis, Joao F. Vieira, Fernando A. S. Mathias, Bruno M. Roatt, Rodrigo Dian D. O. Aguiar-Soares, Jeronimo C. Ruiz, Daniela de M. Resende, Alexandre B. Reis
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Due to an increase in the incidence of leishmaniases worldwide, the development of new strategies such as prophylactic vaccines to prevent infection and decrease the disease have become a high priority. Classic vaccines against leishmaniases were bas
Externí odkaz:
https://doaj.org/article/355544afe97f4caea50c91fec2c0707f
Autor:
Daniela P. Lage, Amanda S. Machado, Camila S. Freitas, Danniele L. Vale, Flávia P. Linhares, Jamille M.O. Cardoso, João A. Oliveira-da-Silva, Fernanda F. Ramos, Isabela A.G. Pereira, Fernanda Ludolf, Grasiele S.V. Tavares, Raquel S. Bandeira, Jamil S. Oliveira, Daniel Menezes-Souza, Mariana C. Duarte, Alexsandro S. Galdino, Myron Christodoulides, Miguel A. Chávez-Fumagalli, Bruno M. Roatt, Vívian T. Martins, Eduardo A.F. Coelho
Publikováno v:
Molecular Immunology. 155:79-90
Autor:
Lage, Danniele L. Vale, Camila S. Freitas, Vívian T. Martins, Gabriel J. L. Moreira, Amanda S. Machado, Fernanda F. Ramos, Isabela A. G. Pereira, Raquel S. Bandeira, Marcelo M. de Jesus, Grasiele S. V. Tavares, Fernanda Ludolf, Miguel A. Chávez-Fumagalli, Alexsandro S. Galdino, Ricardo T. Fujiwara, Lílian L. Bueno, Bruno M. Roatt, Myron Christodoulides, Eduardo A. F. Coelho, Daniela P.
Publikováno v:
Biology; Volume 12; Issue 6; Pages: 851
Visceral leishmaniasis (VL) in the Americas is a chronic systemic disease caused by infection with Leishmania infantum parasites. The toxicity of antileishmanial drugs, long treatment course and limited efficacy are significant concerns that hamper a
Autor:
Jamille M. de O. Cardoso, Bruno M. Roatt, Paula M. de A. Vieira, Nívia C. N. de Paiva, Breno Bernardes-Souza, Oscar C. Lisboa, Rodrigo D. de O. Aguiar-Soares, Alexandre B. Reis, Wendel Coura-Vital, Cláudia M. Carneiro
Publikováno v:
Diagnosis. 9:398-402